207_Combined course Presentations

ESMO-ESGO-ESTRO recommendations 2015

4 risk groups

Risk group

Histology

Adjuvant treatment

With LND

No LND

High

Ib G3

EBRT or BT EBRT (+ chemo)

II G1-2, LVSI -ve II G3 or LVSI +ve

BT EBRT

EBRT EBRT (+ chemo)

III

EBRT (+ chemo)

Colombo N. Radiother Oncol. 2015;117(3):559-81